Biohaven Pharmaceutical Holding Company Ltd. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 11/13/2024 | 7.79 M | $389.06 M | 7.07% | 8.25% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 6.88 M | $343.66 M | 100.00% | 7.29% |
STIFEL FINANCIAL CORP | 11/14/2024 | 6.51 M | $325.27 M | 0.44% | 6.90% |
JANUS HENDERSON GROUP PLC | 11/14/2024 | 6.23 M | $311.14 M | 5.56% | 6.60% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 5.20 M | $259.80 M | 0.00% | 5.51% |
FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 3.64 M | $182.02 M | 62.04% | 3.86% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.44 M | $171.82 M | 4.69% | 3.64% |
STATE STREET CORP | 11/14/2024 | 3.26 M | $162.73 M | -10.78% | 3.45% |
RP MANAGEMENT, LLC | 11/13/2024 | 2.94 M | $146.74 M | 0.00% | 3.11% |
BELLEVUE GROUP AG | 11/14/2024 | 2.04 M | $101.98 M | 0.00% | 2.16% |
FMR LLC | 11/13/2024 | 1.84 M | $92.00 M | -0.71% | 1.95% |
CITADEL ADVISORS LLC | 11/14/2024 | 1.76 M | $87.70 M | -6.49% | 1.86% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.71 M | $85.70 M | 2.64% | 1.82% |
POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 1.50 M | $74.97 M | 745.89% | 1.59% |
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 1.49 M | $74.22 M | 0.00% | 1.57% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 1.48 M | $74.08 M | -22.52% | 1.57% |
ARMISTICE CAPITAL, LLC | 11/14/2024 | 1.20 M | $59.94 M | -14.14% | 1.27% |
REDMILE GROUP, LLC | 11/14/2024 | 1.03 M | $51.68 M | -4.91% | 1.10% |
ARS INVESTMENT PARTNERS, LLC | 10/16/2024 | 1.03 M | $51.48 M | 9.54% | 1.09% |
BROWN ADVISORY INC | 11/13/2024 | 968,359 | $48.39 M | 100.00% | 1.03% |
WOODLINE PARTNERS LP | 11/14/2024 | 923,807 | $46.16 M | 14.46% | 0.98% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 902,888 | $45.12 M | 144.75% | 0.96% |
HOLOCENE ADVISORS, LP | 11/14/2024 | 852,627 | $42.61 M | -49.74% | 0.90% |
JPMORGAN CHASE & CO | 12/26/2024 | 809,448 | $40.45 M | 85.35% | 0.86% |
VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 710,979 | $35.53 M | 9.12% | 0.75% |
ORACLE INVESTMENT MANAGEMENT INC | 11/14/2024 | 705,250 | $35.24 M | 0.69% | 0.75% |
CAPITAL INTERNATIONAL INVESTORS | 11/13/2024 | 671,414 | $33.55 M | 0.00% | 0.71% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 642,376 | $32.10 M | -11.90% | 0.68% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 632,690 | $31.62 M | 5.46% | 0.67% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 592,599 | $29.61 M | 1.28% | 0.63% |
D. E. SHAW & CO., INC. | 11/14/2024 | 577,723 | $28.87 M | 6.90% | 0.61% |
MORGAN STANLEY | 11/14/2024 | 563,877 | $28.18 M | -21.55% | 0.60% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 510,475 | $25.51 M | -0.15% | 0.54% |
VESTAL POINT CAPITAL, LP | 11/14/2024 | 500,000 | $24.99 M | 100.00% | 0.53% |
CLEARBRIDGE INVESTMENTS, LLC | 11/12/2024 | 479,249 | $23.95 M | -0.03% | 0.51% |
5AM VENTURE MANAGEMENT, LLC | 11/14/2024 | 478,972 | $23.93 M | 1.92% | 0.51% |
AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 465,000 | $23.24 M | 3.33% | 0.49% |
CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 401,963 | $20.09 M | -49.88% | 0.43% |
EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 399,827 | $19.98 M | -37.00% | 0.42% |
MARSHALL WACE, LLP | 11/14/2024 | 371,669 | $18.57 M | 252.07% | 0.39% |
VICTORY CAPITAL MANAGEMENT INC | 11/05/2024 | 363,615 | $18.17 M | 67.06% | 0.39% |
AMERIPRISE FINANCIAL INC | 11/14/2024 | 363,351 | $18.16 M | 38.08% | 0.39% |
BISON WEALTH, LLC | 11/05/2024 | 330,988 | $16.54 M | 0.87% | 0.35% |
IKARIAN CAPITAL, LLC | 11/14/2024 | 325,600 | $16.27 M | 100.00% | 0.35% |
FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 315,816 | $15.78 M | -13.72% | 0.33% |
TD ASSET MANAGEMENT INC | 11/01/2024 | 310,842 | $15.85 M | 5.07% | 0.33% |
PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 307,069 | $15.34 M | 128.24% | 0.33% |
SIREN, L.L.C. | 11/13/2024 | 283,540 | $14.17 B | 100.00% | 0.30% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 280,765 | $14.03 M | -16.93% | 0.30% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 275,800 | $13.78 M | 156.32% | 0.29% |
Biohaven Pharmaceutical Holding Company Ltd.institutional Ownership - FAQ's
During the previous two years, 318 institutional investors and hedge funds held shares of Biohaven Pharmaceutical Holding Company Ltd.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 7.79 M
BlackRock Funding, Inc. /DE: 6.88 M
STIFEL FINANCIAL CORP: 6.51 M
JANUS HENDERSON GROUP PLC: 6.23 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 5.2 M
FARALLON CAPITAL MANAGEMENT LLC: 3.64 M
90.49% of Biohaven Pharmaceutical Holding Company Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 98.01 M shares in the last 24 months. This purchase volume represents approximately $3.60 B in transactions.